[HEIM] YoY Annualized Quarter Result on 30-Sep-2022 [#3]

Stock
[HEIM] HEINEKEN MALAYSIA BERHAD
Announcement Date
08-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- 3.01%
YoY- 105.69%
Quarter Report
Latest QR
Upcoming QR
HEIM's Result
HEIM's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 2,631,541 2,545,490 2,751,172 1,716,012 1,657,841 2,186,998 1,823,188 6.30%
PBT 546,800 505,128 587,058 262,704 175,097 389,334 313,832 9.68%
Tax -112,272 -121,490 -176,138 -62,930 -41,732 -93,600 -70,466 8.06%
NP 434,528 383,637 410,920 199,773 133,365 295,734 243,365 10.13%
-
NP to SH 434,528 383,637 410,920 199,773 133,365 295,734 243,365 10.13%
-
Tax Rate 20.53% 24.05% 30.00% 23.95% 23.83% 24.04% 22.45% -
Total Cost 2,197,013 2,161,853 2,340,252 1,516,238 1,524,476 1,891,264 1,579,822 5.64%
-
Net Worth 398,769 359,496 383,664 299,077 296,056 302,098 271,888 6.58%
Dividend
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Div 161,118 161,118 161,118 60,419 - 169,174 161,118 0.00%
Div Payout % 37.08% 42.00% 39.21% 30.24% - 57.20% 66.20% -
Equity
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Net Worth 398,769 359,496 383,664 299,077 296,056 302,098 271,888 6.58%
NOSH 302,098 302,098 302,098 302,098 302,098 302,098 302,098 0.00%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 16.51% 15.07% 14.94% 11.64% 8.04% 13.52% 13.35% -
ROE 108.97% 106.72% 107.10% 66.80% 45.05% 97.89% 89.51% -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 871.09 842.60 910.69 568.03 548.78 723.94 603.51 6.30%
EPS 143.84 126.99 136.03 66.13 44.15 97.89 80.56 10.13%
DPS 53.33 53.33 53.33 20.00 0.00 56.00 53.33 0.00%
NAPS 1.32 1.19 1.27 0.99 0.98 1.00 0.90 6.58%
Adjusted Per Share Value based on latest NOSH - 302,098
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 871.09 842.60 910.69 568.03 548.78 723.94 603.51 6.30%
EPS 143.84 126.99 136.03 66.13 44.15 97.89 80.56 10.13%
DPS 53.33 53.33 53.33 20.00 0.00 56.00 53.33 0.00%
NAPS 1.32 1.19 1.27 0.99 0.98 1.00 0.90 6.58%
Price Multiplier on Financial Quarter End Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 30/09/24 29/09/23 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 -
Price 23.36 24.32 23.88 23.10 20.66 24.00 20.12 -
P/RPS 2.68 2.89 2.62 4.07 3.76 3.32 3.33 -3.55%
P/EPS 16.24 19.15 17.56 34.93 46.80 24.52 24.98 -6.91%
EY 6.16 5.22 5.70 2.86 2.14 4.08 4.00 7.45%
DY 2.28 2.19 2.23 0.87 0.00 2.33 2.65 -2.47%
P/NAPS 17.70 20.44 18.80 23.33 21.08 24.00 22.36 -3.81%
Price Multiplier on Announcement Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 12/11/24 27/11/23 08/11/22 11/11/21 26/11/20 28/11/19 31/10/18 -
Price 22.92 23.38 23.44 22.10 21.00 25.90 18.00 -
P/RPS 2.63 2.77 2.57 3.89 3.83 3.58 2.98 -2.05%
P/EPS 15.93 18.41 17.23 33.42 47.57 26.46 22.34 -5.47%
EY 6.28 5.43 5.80 2.99 2.10 3.78 4.48 5.78%
DY 2.33 2.28 2.28 0.90 0.00 2.16 2.96 -3.90%
P/NAPS 17.36 19.65 18.46 22.32 21.43 25.90 20.00 -2.32%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment